{"id": "chatcmpl-B2RSjYPL4Jn5zsMkbqXmDp7KGICY8", "object": "chat.completion", "created": 1739921921, "model": "gpt-4o-mini-2024-07-18", "choices": [{"index": 0, "message": {"role": "assistant", "content": null, "function_call": {"name": "get_weaksignals", "arguments": "{\"signals\":[{\"name\":\"Emerging Longevity Industry\",\"description\":\"The longevity sector is increasingly recognized as a distinct industry separate from biotech and healthcare.\",\"change\":\"Recognition of longevity as its own industry rather than being classified together with other healthcare sectors.\",\"10-year\":\"The longevity industry could evolve into a major economic sector with specialized regulations and standards.\",\"driving-force\":\"Increased private funding and technological advancements in aging research drive this change.\",\"relevancy\":4},{\"name\":\"Introductory Capital Influx\",\"description\":\"2022 saw a record-breaking influx of capital into longevity startups, totaling $6.96 billion.\",\"change\":\"Shifting perceptions about aging, leading to a burgeoning market for longevity interventions.\",\"10-year\":\"The growth of a mature investment ecosystem focused on longevity and aging interventions.\",\"driving-force\":\"Investors' recognition of aging as a significant market opportunity catalyzes funding.\",\"relevancy\":5},{\"name\":\"Concentration of Funding in the U.S.\",\"description\":\"The majority of longevity funding rounds are concentrated in the United States, accounting for 75%.\",\"change\":\"The global investment landscape in longevity is regionally unbalanced, with the U.S. dominating.\",\"10-year\":\"Potential rise of global competition as other nations grow their aging innovation sectors.\",\"driving-force\":\"Localized investment climates and research ecosystems strengthen U.S. dominance.\",\"relevancy\":3},{\"name\":\"Shift Towards Early-Stage Funding\",\"description\":\"Most funding rounds in 2022 were at Seed or Series A stages, indicating the industry's youth.\",\"change\":\"Transition from early-stage investments to later-stage funding as companies mature.\",\"10-year\":\"A potential ecosystem where a broader range of companies spans the lifespan of funding stages.\",\"driving-force\":\"Investors\u2019 growing acceptance of high-risk early-stage investments in longevity.\",\"relevancy\":4},{\"name\":\"Impact of High-Profile Investment\",\"description\":\"Altos Labs raised $3 billion in a Series A financing, significantly influencing the funding landscape.\",\"change\":\"A single company's massive funding alters average deal sizes and investment perceptions in longevity.\",\"10-year\":\"Attraction of more similar high-profile investments towards large-scale aging research projects.\",\"driving-force\":\"Success of high-profile financing rounds attracts further investments and validation.\",\"relevancy\":4}]}"}, "refusal": null}, "logprobs": null, "finish_reason": "function_call"}], "usage": {"prompt_tokens": 1419, "completion_tokens": 465, "total_tokens": 1884, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_13eed4fce1"}